|
| Sineptina Basic information |
Product Name: | Sineptina | Synonyms: | LEUCOMYCIN HYDRATE;KITASAMYCIN BASE;KITASAMYCIN;FORMACIDINE;ayermicina;2-[6-[[5-[(4,5-dihydroxy-4,6-dimethyl-2-oxanyl)oxy]-4-(dimethylamino)-3-hydroxy-6-methyl-2-oxanyl]oxy]-4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde;Leucomycin complex;Kitasamycin Solution, 1000ppm | CAS: | 1392-21-8 | MF: | C35H59NO13 | MW: | 701.84186 | EINECS: | 232-429-6 | Product Categories: | | Mol File: | 1392-21-8.mol | |
| Sineptina Chemical Properties |
Melting point | 128-145 °C | storage temp. | Sealed in dry,2-8°C | solubility | ethanol: 50 mg/mL, clear to slightly hazy, light-yellow | form | neat | color | White to Off-White | Merck | 14,5453 | CAS DataBase Reference | 1392-21-8 |
Safety Statements | 24/25 | WGK Germany | 1 | RTECS | WG9400000 | F | 10 | HS Code | 29419090 | Toxicity | mouse,LD50,intraperitoneal,1758mg/kg (1758mg/kg),Drugs in Japan Vol. -, Pg. 354, 1995. |
| Sineptina Usage And Synthesis |
Uses | Sineptina is a family of closely related macrocyclic lactone antibiotics produced by Streptomyces kitasatoensis, discovered in 1953. The complex contained over 14 components with analogues A1, A4, A5, and A13 being the most abundant analogues.Sineptina is used as an animal health product for control of Gram positive bacteria, Gram negative cocci, leptospira and mycoplasma.
| Uses | Leucomycins (>85%) (cas# 1392-21-8) is a compound useful in organic synthesis. | Definition | ChEBI: Leucomycin V is a macrolide antibiotic produced by Streptomyces kitasatoensis, showing activity against a wide spectrum of pathogens. It has a role as a bacterial metabolite. It is a leucomycin and a macrolide antibiotic. | Pharmaceutical Applications | A naturally occurring product of Streptomyces kitasatoensis, available in Japan for parenteral and oral use, and as acetylkitasamycin for topical application. Elsewhere it is chiefly used in veterinary medicine. |
| Sineptina Preparation Products And Raw materials |
|